Published in Blood Weekly, February 1st, 1999
Although disease-free survival (DFS) continues to improve after unrelated bone marrow transplantation (BMT), fatal opportunistic infections still frequently occur.
T.N. Small and colleagues of New York's Memorial Sloan-Kettering Cancer Center evaluated features unique to immune reconstitution following unrelated BMT ("Comparison of Immune Reconstitution after Unrelated and Related T-Cell-Depleted Bone Marrow Transplantation: Effect of Patient Age and Donor Leukocyte Infusions," Blood,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1999-02-01)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.